AiLux is seeking a Senior Director of Drug Safety in Cambridge, UK, to lead and establish its nonclinical safety strategies across innovative drug development. This pivotal role will involve establishing safety assessments for biologics, multi-specific antibodies, and peptide therapeutics, reporting directly to the VP of In Vivo Bioscience.

The ideal candidate will have extensive expertise in toxicology and pharmacology, with a background in overseeing regulatory submissions. This is a strategic leadership role, offering the chance to shape the future of AiLux's safety science capabilities.